Date:2/17/2011

Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation, development, production and sales of high-value products from microbial sources that promote health and wellness through nutrition.  The company is the world's leading provider of algal DHA omega-3 with its flagship product, life'sDHA™, a sustainable and vegetarian source of algal DHA omega-3 important for brain, heart and eye health throughout life, for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA™ (arachidonic acid), an omega-6 fatty acid, for use in infant formula and growing up milks. Additionally, Martek's subsidiary, Amerifit Brands, develops, markets and distributes branded consumer health and wellness products in major mass, club, drug, grocery and specialty stores and holds leading brand positions in all of its key product categories. For more information on Martek Biosciences, visit http://www.martek.com/. For information about life'sDHA or life'sARA products, visit www.lifesdha.com/ or www.algaldha.com. For more information about Amerifit Brands, visit www.amerifit.com.

Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2010 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.Contact:Cassie France-KellyPublic Relations (443)
'/>"/>

SOURCE Martek Biosciences Corporation Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years
2. Martek Announces Fourth Quarter and FY 2010 Financial Results
3. Martek to Present at Upcoming Citi Small / Mid Cap Conference
4. Martek to Present at Upcoming UBS Conference
5. Martek Announces Third Quarter FY 2010 Financial Results
6. Martek Announces Fourth Quarter and FY 2009 Financial Results
7. Martek Signs Sole-Source Supply Agreement with Fonterra
8. Martek to Announce Fourth Quarter and Fiscal Year 2009 Results
9. Martek Announces Addition to Its Board of Directors
10. Martek to Present at Two Upcoming Investor Conferences
11. Martek Announces Settlement of Patent Dispute with Capsugel France